Business Description
Disc Medicine Inc
NAICS : 325412
SIC : 2834
Description
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 180.41 | |||||
| Equity-to-Asset | 0.97 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.48 | |||||
| 9-Day RSI | 32.14 | |||||
| 14-Day RSI | 39.17 | |||||
| 6-1 Month Momentum % | 154.05 | |||||
| 12-1 Month Momentum % | 301.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 39.42 | |||||
| Quick Ratio | 39.42 | |||||
| Cash Ratio | 39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -56.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -31.87 | |||||
| ROA % | -30.18 | |||||
| ROIC % | -2663.16 | |||||
| ROC (Joel Greenblatt) % | -4308.5 | |||||
| ROCE % | -33.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.03 | |||||
| Price-to-Tangible-Book | 3.01 | |||||
| EV-to-EBIT | -10.98 | |||||
| EV-to-Forward-EBIT | -7.03 | |||||
| EV-to-EBITDA | -11 | |||||
| EV-to-FCF | -11 | |||||
| Price-to-Net-Current-Asset-Value | 3.03 | |||||
| Price-to-Net-Cash | 3.06 | |||||
| Earnings Yield (Greenblatt) % | -9.11 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IRON
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Disc Medicine Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.96 | ||
| Beta | 0 | ||
| Volatility % | 56.86 | ||
| 14-Day RSI | 39.17 | ||
| 14-Day ATR ($) | 2.620374 | ||
| 20-Day SMA ($) | 52.969 | ||
| 12-1 Month Momentum % | 301.09 | ||
| 52-Week Range ($) | 11.8 - 57.7 | ||
| Shares Outstanding (Mil) | 22.88 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Disc Medicine Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Disc Medicine Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Disc Medicine Inc Frequently Asked Questions
What is Disc Medicine Inc(IRON)'s stock price today?
The current price of IRON is $48.91. The 52 week high of IRON is $57.70 and 52 week low is $11.80.
When is next earnings date of Disc Medicine Inc(IRON)?
The next earnings date of Disc Medicine Inc(IRON) is 2023-11-10 Est..
Does Disc Medicine Inc(IRON) pay dividends? If so, how much?
Disc Medicine Inc(IRON) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers